Why this is a checklist and not a ranking
Buying a compounded GLP-1 medication online means trusting three parties you will probably never meet: a prescriber, a pharmacy and the platform that connects them. The FDA and LegitScript have each published what a legitimate arrangement looks like, and this guide turns those published standards into a set of things to verify before ordering, questions to ask, red flags to walk away from, and a way to compare prices that does not mislead. It names no providers and ranks nothing. Bodi Envi appears once, at the end, as a labelled example of how the checks read against one platform’s published facts.
This is general information and not medical advice. Personalized Compounded semaglutide and tirzepatide are not FDA-approved and are not equivalent to the approved products, and the FDA’s position is that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Whether treatment of any kind is appropriate for you is a decision for a licensed provider.
What to verify first
The FDA’s BeSafeRx campaign, on its page for consumers considering an online pharmacy, gives four safe signs. An online pharmacy is likely safe if it always requires a doctor’s prescription, provides a physical address and telephone number in the United States, has a licensed pharmacist on staff to answer your questions, and is licensed with a state board of pharmacy. The FDA’s consumer update on buying medicines online adds a way to check the last of those: look the pharmacy up in the state board of pharmacy license database, and if it is not listed, do not use it. For a telehealth platform, the FDA’s compounding questions and answers page notes that consumers who buy compounded drugs online may not know the identity of the compounder that produced the drug, including whether it is appropriately licensed and regulated, and it encourages consumers to research the online pharmacy before using its services.
That gives the first five things to verify, in order.
A licensed prescriber who evaluates you. The FDA’s statement on unapproved GLP-1 drugs advises patients to obtain a prescription from their doctor, and lists a site that does not require a screening and prescription by a licensed doctor among the warning signs. A legitimate platform names the clinical organization whose providers review patients and states that a licensed provider decides whether treatment is appropriate.
A state-licensed pharmacy you can identify. The FDA’s advice is to fill the prescription at a state-licensed pharmacy. A legitimate platform names its pharmacy partner or tells you the pharmacy’s name and contact details will be on your prescription label, and that name can be checked in the relevant state board’s license database.
A LegitScript listing. LegitScript’s healthcare certification standards, on its certification page, require a merchant to be adequately licensed for the services it offers and in the jurisdictions it serves, including where medications are prescribed and dispensed and where the patient is located; to dispense prescription drugs only on receipt of a valid prescription; to comply with applicable privacy law; to have no recent or repeated disciplinary sanctions or warning letters; and to ensure that all practices, offers and advertising are accurate, transparent and not misleading. LegitScript publishes a website checker at legitscript.com/websites where a domain can be looked up; a badge on a page is a claim, and the checker is the verification. Certification is a statement about a merchant’s compliance, not FDA approval of any medication.
Published pricing. The FDA lists prices that seem too good to be true among its warning signs, but the more useful test is whether the price is published at all, with what it includes and what happens if a provider does not prescribe. A price that appears only after you have entered payment details is a warning in itself.
Published cancellation and refund terms. LegitScript’s standards require offers to be transparent, and a platform that meets them publishes how to cancel, what is refundable and when, and what happens to medication that has already been dispensed.
Questions to ask before you order
The verifications above turn into questions a platform should be able to answer from its own published pages. Who is the clinical organization, and does a licensed provider review my assessment before any prescription? Which pharmacy will prepare my medication, in which state is it licensed, and will its name and contact details be on my label? Is the site listed as certified on LegitScript’s checker? What exactly does the price include, does it change with dose, and what is refunded if the provider decides not to prescribe? What are the cancellation terms, and where are they published? Is there a licensed clinician I can contact after the medication arrives? What are the storage instructions, and what should I do if the medication arrives warm?
A platform that answers all of those from its own pages, without needing a phone call, is doing what the FDA and LegitScript describe.
Red flags the FDA names
The FDA’s BeSafeRx page and its consumer update list the warning signs of an unsafe online pharmacy, and its statement on unapproved GLP-1 drugs adds signs specific to compounded products. Combined, they are the list to walk away from.
From BeSafeRx: the site does not require a doctor’s prescription; it is not licensed in the United States and by your state board of pharmacy; it has no licensed pharmacist on staff to answer questions; it sends medicine that looks different from what you receive at a local pharmacy, or that arrives in packaging that is broken, damaged, in a foreign language, expired or without an expiration date; it offers deep discounts or prices that seem too good to be true; it charges you for products you never ordered or received; or it does not provide clear written protection of your personal and financial information, or sells it to other websites.
From the GLP-1 statement: the seller claims the compounded drug is the same as an FDA-approved drug; it sends medicine that looks different from what was pictured or previously received, or without instructions for use; it does not require a screening and prescription by a licensed doctor; it has no licensed doctor available afterwards; the label has spelling errors or an incorrect pharmacy address; the pharmacy name might be fraudulent. The statement also reports products with labels naming pharmacies that do not exist or did not make them, semaglutide salt forms that are different active ingredients from the approved drug, products falsely labelled for research purposes or not for human consumption, and compounded products arriving warm, which the FDA says not to use.
Any one of those is enough. The FDA’s consumer update explains why: medicines from unsafe sites may have too much or too little active ingredient, the wrong ingredient, harmful substances, or may have been stored without temperature control.
How to compare prices honestly
Prices for compounded GLP-1 programs are hard to compare because they are not measuring the same thing. Four questions make them comparable.
What is included. Some prices cover a program: the assessment, provider review, ongoing messaging and the medication when prescribed. Some cover the medication alone, with a separate consultation fee, or the consultation alone, with medication billed by the pharmacy. Read what the price buys before reading the number.
Whether the price changes with dose. A price that rises at each step of the escalation the labels describe is a different cost over a course of treatment from one that stays flat. Ask, and look for the answer in writing.
What happens if the provider does not prescribe. Completing an assessment should not guarantee a prescription, and a legitimate platform says so. What you pay in that case, and what is refunded, should be in the published refund policy.
What the cancellation terms are. A monthly price and a prepaid price for several months are different commitments, and the refund policy is where the difference lives. Read it before choosing a term, not after.
A price that is low because a step has been skipped, no provider review or no identifiable pharmacy, is not a saving. It is one of the FDA’s warning signs.
Bodi Envi as one labelled example
Read against the checklist, Bodi Envi’s published facts are these. It states that it is a LegitScript-certified U.S. telehealth platform and publishes a verification link to LegitScript’s website checker for its domain on every page. It states that it is not a medical practice, pharmacy or medication manufacturer, that clinical services for applicable programs are provided by Wasef Health, PC, and that a licensed healthcare provider determines whether treatment is appropriate for each individual patient; completing an assessment does not guarantee a prescription. It states that prescriptions are dispensed by third party U.S. 503A licensed compounding pharmacies, that VialsRx is the current pharmacy partner for applicable GLP-1 prescriptions, that availability may vary by program and location, and that the prescription label and care team will confirm the pharmacy that applies. Its pricing is on the Plans page, from $155 to $125 per month for personalized compounded semaglutide and $229 to $175 for personalized compounded tirzepatide depending on term, and it states that for applicable programs pricing does not increase based solely on dosage strength. Cancellation and refunds are governed by its published cancellation policy, which accepts requests through the patient portal or by email before the provider review and states that dispensed medications are non-refundable once an order has been processed or shipped. Its programs include a GLP-1 ebook and diet plan and messaging with the care team through the patient portal after medication arrives.
Those are Bodi Envi’s own published statements, offered as an example of what the checklist looks like when the answers are in writing, not as a comparison with anyone else. Apply the same checks to any platform, including this one. Personalized Compounded semaglutide and tirzepatide are not FDA-approved and are not equivalent to the approved products; the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. This guide is general information and not medical advice, and a licensed provider is the person who decides whether treatment is appropriate for you.